For its first fiscal quarter (ending March 31), Merck & Co Inc (NYSE: MRK) has reported E.P.S. of $1.87 compared to $1.11 a year ago. For the latest four quarters through March 31, E.P.S. were $0.91 compared to $5.13 a year ago.
Recent Price Action
Merck & Co Inc (NYSE: MRK) stock closed at $130.72 on 4/25/24 after a large increase of 2.9%. Moreover, trading volume in this advance was above average at 148% of normal. The stock has risen 4.3% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
MRK’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Merck has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Merck has a neutral Appreciation Score of 56 but a good Power Rating of 79, with the Positive Value Trend Rating the result.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment